Nektar Therapeutics Public
Nektar's new pathways to smarter medicine bring hope to millions of patients by creating innovative medicines that treat serious & widespread unmet medical needs.
Total Funding:
1200000000
Technology:
Biotechnology, Chemical, Health Care, Therapeutics
Last Funding Type:
Post-IPO Equity
Estimated Revenue:
$50M to $100M
Founded Date:
1990
Industry:
PharmTech
Employee Number:
501-1000
Acquisitions Number:
2.0
Funding Status:
IPO
Number Of Exists:
1
Headquarters:
San Carlos, California, United States